EyeGate Pharma names new CEO, shares surge
** Eye drug developer's shares EYEG.O jump as much as
89.3% to $5.9 in extended trading
** Co names Brian Strem as president, CEO and board member,
effective immediately urn:newsml:reuters.com:*:nGNX3lYGzl
** Strem is former CEO of biotech co Okogen and co-founder,
managing director of Bayon Therapeutics
** EyeGate says it has also entered into a non-binding
letter of intent to acquire Bayon
** Stock down ~36% YTD, as of last close
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing